Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Marginal Zone Lymphoma, Lenalidomide

Nishitha Reddy

MD, MSCI

🏢Vanderbilt University Medical Center🌐USA

Associate Professor of Medicine

33
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Nishitha Reddy investigates lenalidomide-based regimens in indolent lymphomas including marginal zone lymphoma, particularly evaluating the R2 (rituximab plus lenalidomide) combination as a chemotherapy-free approach. Her work addresses the optimal sequencing of immunomodulatory agents following anti-CD20 therapy failure. She has also contributed to studies on novel immune-targeted approaches for previously treated MZL.

Share:

🧪Research Fields 研究领域

lenalidomide MZL
lenalidomide R2 regimen
immunomodulatory therapy lymphoma
MZL relapsed treatment
clinical trials lymphoma

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Nishitha Reddy 的研究动态

Follow Nishitha Reddy's research updates

留下邮箱,当我们发布与 Nishitha Reddy(Vanderbilt University Medical Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment